Article
Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2015
Tsai Shu-Chun, Shih Lee-Yung, Liang Sung-Tzu, Huang Ying-Jung, Kuo Ming-Chung, Huang Chein-Fuang, Shih Yu-Shu, Lin Tung-Huei, Chiu Ming-Chun, Liang Der-Cherng
Abstract excerpt
PURPOSE: Transcription factor RUNX1 is essential for normal hematopoiesis. High mutation frequencies of RUNX1 gene in chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) have been described, whereas the biologic significances of the mutations were not investigated. Here, we aimed to correlate the biologic activities of the RUNX1 mutants with the clinical outcomes of patients. EXPERIMENTAL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
